Krka, d. d.
KRK
Κατάταξη σε μετοχές
#2128
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Τιμή μετοχής
$318.12
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$9.63B
Αλλαγή (1 ημέρα)
0.18%
Αλλαγή (1 έτος)
29.20%
Χώρα
SI
Εμπόριο Krka, d. d. (KRK)
Κατηγορία
Healthcare
Κέρδη για την Krka, d. d. (KRK)
Κέρδη τον Jun 2026 TTM: $613.56M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Krka, d. d., τα τρέχοντα κέρδη της εταιρείας είναι $613.56M. Το 2023, η εταιρεία παρουσίασε κέρδη $405.84M, μείωση σε σύγκριση με των κερδών του 2022 που ήταν $464.55M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Krka, d. d. από 2010 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $613.56M | 40.70% |
| 2024 | $436.08M | 7.45% |
| 2023 | $405.84M | -12.64% |
| 2022 | $464.55M | 12.72% |
| 2021 | $412.12M | -0.18% |
| 2020 | $412.85M | 29.40% |
| 2019 | $319.06M | 37.06% |
| 2018 | $232.79M | 10.12% |
| 2017 | $211.39M | 72.75% |
| 2016 | $122.37M | -37.64% |
| 2015 | $196.22M | -7.49% |
| 2014 | $212.12M | -23.39% |
| 2013 | $276.88M | 10.18% |
| 2012 | $251.29M | -2.93% |
| 2011 | $258.87M | -8.40% |
| 2010 | $282.60M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 187.59% |
IN
|
